Bernd Meibohm

University Of Tennessee Health Sci Ctr

$2,938,789

Attributed

$9,081,927

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY2014–25

$2M$1.5M$1M$500K$0

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$9,081,927 · 4

By mechanism

R01$8,766,276 · 3

S10$315,651 · 1

Top collaborators

Others in their field

Top investigators on “Drug Kinetics”

Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
Sharon A Nachman · Johns Hopkins University$194,646,762
Carol Nesel · Westat$147,274,423
Barbara Driver · Westat, Inc.$103,746,400
Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869

Research focus

Drug KineticsPropertyUniversitiesTennesseeColoradoAerosolsFrequenciesIn VitroRouteRegimenPowder Dose FormFormulationLungTissuesOrganSafetyDosePharmaceutical PreparationsBiological AvailabilityAnimal ModelIn VivoDrug Or Chemical Tissue DistributionAntibioticsFuture